<DOC>
	<DOC>NCT00185419</DOC>
	<brief_summary>The purpose of this study is to evaluate the effectiveness in terms of prevention of pregnancy and safety of the oral contraceptive Yasmin and Marvelon on cycle control in healthy Chinese women</brief_summary>
	<brief_title>A Clinical Study on Yasmin® vs. Marvelon® in Chinese Women Requiring Contraception</brief_title>
	<detailed_description>The study has previously been posted by Schering AG, Germany. Schering AG, Germany has been renamed to Bayer Schering Pharma AG, Germany. Bayer Schering Pharma AG, Germany is the sponsor of the trial.</detailed_description>
	<mesh_term>Drospirenone</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Desogestrel</mesh_term>
	<mesh_term>Drospirenone and ethinyl estradiol combination</mesh_term>
	<criteria>Healthy Chinese female requesting contraceptives Vascular, metabolic, hepatic, renal, oncologic and other diseases</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>January 2009</verification_date>
</DOC>